PL2288376T3 - Sposoby generowania i wykorzystywania prokolagenu - Google Patents

Sposoby generowania i wykorzystywania prokolagenu

Info

Publication number
PL2288376T3
PL2288376T3 PL09733363T PL09733363T PL2288376T3 PL 2288376 T3 PL2288376 T3 PL 2288376T3 PL 09733363 T PL09733363 T PL 09733363T PL 09733363 T PL09733363 T PL 09733363T PL 2288376 T3 PL2288376 T3 PL 2288376T3
Authority
PL
Poland
Prior art keywords
procollagen
generating
methods
Prior art date
Application number
PL09733363T
Other languages
English (en)
Inventor
Oded Shoseyov
Or Dgany
Daniel L Siegel
Original Assignee
Collplant Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collplant Ltd filed Critical Collplant Ltd
Publication of PL2288376T3 publication Critical patent/PL2288376T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
PL09733363T 2008-04-18 2009-04-16 Sposoby generowania i wykorzystywania prokolagenu PL2288376T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7126708P 2008-04-18 2008-04-18
US12997608P 2008-08-04 2008-08-04
EP09733363.7A EP2288376B1 (en) 2008-04-18 2009-04-16 Methods of generating and using procollagen
PCT/IL2009/000419 WO2009128076A2 (en) 2008-04-18 2009-04-16 Methods of generating and using procollagen

Publications (1)

Publication Number Publication Date
PL2288376T3 true PL2288376T3 (pl) 2016-07-29

Family

ID=41066758

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09733363T PL2288376T3 (pl) 2008-04-18 2009-04-16 Sposoby generowania i wykorzystywania prokolagenu

Country Status (7)

Country Link
US (2) US9095569B2 (pl)
EP (2) EP2288376B1 (pl)
CN (2) CN104491845A (pl)
CA (1) CA2721507C (pl)
ES (1) ES2565185T3 (pl)
PL (1) PL2288376T3 (pl)
WO (1) WO2009128076A2 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2565185T3 (es) 2008-04-18 2016-04-01 Collplant Ltd. Métodos de generación y de uso del procolágeno
EP2688498A1 (en) * 2011-03-21 2014-01-29 Ronald Childs Sleeve for bone fixation device
US9782457B2 (en) * 2011-10-07 2017-10-10 Tissue Repair Company Flowable formulations for tissue repair and regeneration
US20180126033A9 (en) 2012-03-14 2018-05-10 MAM Holdings of West Florida, L.L.C. Collagen compositions and uses for biomaterial implants
US10576037B2 (en) * 2012-03-14 2020-03-03 MAM Holdings of West Florida, L.L.C. Compositions comprising placental collagen for use in wound healing
US10485521B2 (en) 2013-05-10 2019-11-26 MAM Holdings of West Florida, L.L.C. Method for obtaining sterile human amniotic fluid and uses thereof
US20140336600A1 (en) 2013-05-10 2014-11-13 Carl Randall Harrell Method for Obtaining Sterile Human Amniotic Fluid and Uses Thereof
US9370603B2 (en) * 2014-03-14 2016-06-21 Suneva Medical, Inc. Injectable alloplastic implants and methods of use thereof
US9370469B2 (en) * 2014-03-14 2016-06-21 Suneva Medical, Inc Injectable alloplastic implants and methods of use thereof
CH709509A1 (de) * 2014-04-03 2015-10-15 Stiftung Für Plastische Und Aesthetische Wundheilung Im Sondervermögen Der Dt Deutschen Stiftungstre Applikationsbeutel mit einer festen aktiven Substanz zur Behandlung von offenen Wunden.
CN104523341B (zh) * 2014-12-18 2017-06-20 中国人民解放军第四军医大学 具有牙周生物活性的即刻种植牙的制造方法
WO2016109722A1 (en) 2014-12-30 2016-07-07 Southwest Technologies, Inc. Composition and methods for treating ischemic wounds and inflammatory conditions
US11273183B2 (en) 2015-10-09 2022-03-15 MAM Holdings of West Florida, L.L.C. Amniotic fluid formulation for treatment of joint pain or disorders
WO2017062948A1 (en) 2015-10-09 2017-04-13 Mam Holdings Of West Florida, Llc Amniotic fluid topical formulation for the treatment of eye disorders
US9907821B2 (en) 2015-10-09 2018-03-06 MAM Holdings of West Florida, L.L.C. Amniotic fluid formulation for treatment of joint pain or disorders
KR20170049784A (ko) * 2015-10-28 2017-05-11 재단법인 아산사회복지재단 섬유화 무세포 진피 기질 및 생체적합성 고분자를 포함하는 창상 피복재 및 이의 제조 방법
TWI612057B (zh) * 2015-10-28 2018-01-21 大江生醫股份有限公司 可促進傷口癒合、膠原蛋白增生、血管新生、活化免疫細胞並降低傷口感染之胜肽及其應用
TWI612058B (zh) * 2016-03-25 2018-01-21 台灣醫佳生物科技有限公司 一種自非人類結締組織分離的蛋白質粗萃物及其方法與用途
US20170354692A1 (en) 2016-06-13 2017-12-14 MAM Holdings of West Florida, L.L.C. Amniotic fluid formulation for treatment of lung disorders
TWI598106B (zh) * 2016-08-04 2017-09-11 Use of hemoprotein binding protein subunit-containing proteins for the manufacture of a medicament for promoting wound healing
KR101710615B1 (ko) * 2016-09-07 2017-02-27 주식회사 파마리서치프로덕트 생착률을 증가시킨 이식용 진피층 및 이의 제조 방법
US10517989B1 (en) 2016-11-23 2019-12-31 Jonathan F. Arnold Enhanced medical dressing apparatus, system, and method
EP3646533B1 (en) * 2017-06-27 2023-08-02 Telefonaktiebolaget LM Ericsson (PUBL) Inline stateful monitoring request generation for sdn
US11666446B2 (en) 2017-07-21 2023-06-06 Warsaw Orthopedic, Inc. Bone implant for enclosing bone material
CA3074440A1 (en) * 2017-09-01 2019-03-07 Excel Med, Llc Pharmaceutical composition for treating keloid and uses thereof
WO2019089944A1 (en) * 2017-11-03 2019-05-09 Kci Usa, Inc. Nutrient-enriched dressing
WO2020026241A1 (en) 2018-07-31 2020-02-06 Collplant Ltd. Tobacco transgenic event and methods for detection and use thereof
CN112386682B (zh) * 2020-02-12 2022-12-06 王斌 纤连蛋白在制备治疗新型冠状病毒肺炎药物中的应用
WO2021249013A1 (en) * 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Vaccine compositions, methods, and uses thereof
CN112772789B (zh) * 2020-12-31 2023-05-09 内江师范学院 石榴皮饲料用功能添加剂、制备方法及应用
KR20230131875A (ko) * 2021-01-12 2023-09-14 로리아 파마슈티컬, 엘엘씨 콜라겐 성장을 위한 주사 가능한 필러 (filler) 및스케폴드(scaffold)로서 유용한 다중점도 수중 오일 (OIL-IN-WATER) 조성물
CN113683678B (zh) * 2021-09-15 2023-11-24 山西锦波生物医药股份有限公司 一种重组i型人源化胶原蛋白c1l2t及其制备方法和用途
DE102021214899A1 (de) * 2021-12-22 2023-06-22 Gelita Ag Typ I-Kollagenpeptid zur therapeutischen Verwendung

Family Cites Families (138)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US586398A (en) 1897-07-13 Water-regulator
US3121049A (en) 1960-09-19 1964-02-11 Nihon Hikaku Method for colloidally dispersing collagen
US3131130A (en) 1961-07-31 1964-04-28 Ethicon Inc Method of producing soluble collagen
US3314861A (en) 1963-05-11 1967-04-18 Fujii Tadahiko Method for solubilizing insoluble collagen fibers
US3530037A (en) 1967-03-20 1970-09-22 Tomio Nishihara Method for solubilization of collagen fibers with proteolytic enzymes
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
NL154599B (nl) 1970-12-28 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (nl) 1972-05-11 1983-06-01 Akzo Nv Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
DE2437090A1 (de) 1974-08-01 1976-02-19 Hoechst Ag Reinigungsmittel
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3949073A (en) 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
US4060081A (en) 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
US3934852A (en) 1975-08-11 1976-01-27 Wesbar Corporation Trailer tongue jack
US4233360A (en) 1975-10-22 1980-11-11 Collagen Corporation Non-antigenic collagen and articles of manufacture
US4488911A (en) 1975-10-22 1984-12-18 Luck Edward E Non-antigenic collagen and articles of manufacture
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4016877A (en) 1976-02-23 1977-04-12 Avicon, Inc. Fibrous collagen derived web having hemostatic and wound sealing properties
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
CA1192510A (en) 1981-05-27 1985-08-27 Lawrence E. Pelcher Rna plant virus vector or portion thereof, a method of construction thereof, and a method of producing a gene derived product therefrom
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4578067A (en) 1982-04-12 1986-03-25 Alcon (Puerto Rico) Inc. Hemostatic-adhesive, collagen dressing for severed biological surfaces
US4865871A (en) 1983-08-23 1989-09-12 Board Of Regents The University Of Texas System Method for cryopreparing biological tissue
US5024830A (en) 1983-08-23 1991-06-18 The Board Of Regents, The University Of Texas Method for cryopreparing biological tissue for ultrastructural analysis
JPS6054684A (ja) 1983-09-05 1985-03-29 Teijin Ltd 新規dνa及びハイブリツドdνa
US4601896A (en) 1984-03-21 1986-07-22 Mark Nugent Pharmaceutical capsule compositions and structures for gastric sensitive materials
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4606910A (en) 1984-06-28 1986-08-19 Interface Biomedical Laboratories Composite hemostatic article including a hemostatic agent onlay and methods for preparing the same
US4789663A (en) 1984-07-06 1988-12-06 Collagen Corporation Methods of bone repair using collagen
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
CA1288073C (en) 1985-03-07 1991-08-27 Paul G. Ahlquist Rna transformation vector
US4642117A (en) 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
GB8608850D0 (en) 1986-04-11 1986-05-14 Diatech Ltd Packaging system
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5460939A (en) 1986-04-18 1995-10-24 Advanced Tissue Sciences, Inc. Temporary living skin replacement
US5032508A (en) 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US4773393A (en) 1986-07-03 1988-09-27 C. R. Bard, Inc. Hypodermically implantable genitourinary prosthesis
JPS6314693A (ja) 1986-07-04 1988-01-21 Sumitomo Chem Co Ltd 植物ウイルスrnaベクタ−
ATE108828T1 (de) 1987-02-09 1994-08-15 Lubrizol Genetics Inc Hybrides rns-virus.
GB8708009D0 (en) 1987-04-03 1987-05-07 Clayton Found Res Injectable soft tissue augmentation materials
US5273900A (en) 1987-04-28 1993-12-28 The Regents Of The University Of California Method and apparatus for preparing composite skin replacement
CA1322262C (en) 1987-06-26 1993-09-21 Yoshito Ikada Artificial skin
US4950699A (en) 1988-01-11 1990-08-21 Genetic Laboratories, Inc. Wound dressing incorporating collagen in adhesive layer
US5316931A (en) 1988-02-26 1994-05-31 Biosource Genetics Corp. Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
US4975526A (en) 1989-02-23 1990-12-04 Creative Biomolecules, Inc. Bone collagen matrix for zenogenic implants
US4837379A (en) 1988-06-02 1989-06-06 Organogenesis Inc. Fibrin-collagen tissue equivalents and methods for preparation thereof
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US5693507A (en) 1988-09-26 1997-12-02 Auburn University Genetic engineering of plant chloroplasts
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
DE3841401A1 (de) 1988-12-08 1990-06-13 Martin Lemperle Alloplastisches implantat
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5196185A (en) 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
IL95429A (en) 1989-09-15 1997-09-30 Organogenesis Living tissue equivalents comprising hydrated collagen lattice and a collagen gel and their production
US5256418A (en) 1990-04-06 1993-10-26 Organogenesis, Inc. Collagen constructs
US5645591A (en) 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US5073371A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5073372A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5593859A (en) 1991-10-23 1997-01-14 Thomas Jefferson University Synthesis of human procollagens and collagens in recombinant DNA systems
US5281422A (en) 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
GB9210574D0 (en) 1992-05-18 1992-07-01 Ca Nat Research Council Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
GB2275685B (en) 1993-03-03 1997-04-30 Johnson & Johnson Medical Water soluble wound dressing materials
US5667487A (en) 1993-04-07 1997-09-16 Henley; Julian L. Ionosonic drug delivery apparatus
US5951583A (en) 1993-05-25 1999-09-14 Vascular Solutions, Inc. Thrombin and collagen procoagulant and process for making the same
GB9400163D0 (en) 1994-01-06 1994-03-02 Geistlich Soehne Ag Membrane
US5385561A (en) 1994-01-18 1995-01-31 Bard International, Inc. Apparatus and method for injecting a viscous material into the tissue of a patient
US5489304A (en) 1994-04-19 1996-02-06 Brigham & Women's Hospital Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
DE69732226T2 (de) 1995-03-27 2005-12-22 SDGI Holdings, Inc., Wilmington Wirbelsäulenfusionsimplantat und einführ- und überprüfungswerkzeuge
US5645084A (en) 1995-06-07 1997-07-08 Danek Medical, Inc. Method for spinal fusion without decortication
US5676967A (en) 1995-04-18 1997-10-14 Brennen Medical, Inc. Mesh matrix wound dressing
US5591444A (en) 1995-07-28 1997-01-07 Isolagen Technologies, Inc. Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
WO1997006837A1 (en) 1995-08-16 1997-02-27 Integra Lifesciences Corporation Perforated artificial skin grafts
ES2201193T3 (es) * 1995-08-31 2004-03-16 The Victoria University Of Manchester Nuevos procolagenos.
US6087549A (en) 1997-09-22 2000-07-11 Argentum International Multilayer laminate wound dressing
US5776193A (en) 1995-10-16 1998-07-07 Orquest, Inc. Bone grafting matrix
US6095148A (en) 1995-11-03 2000-08-01 Children's Medical Center Corporation Neuronal stimulation using electrically conducting polymers
US6007802A (en) 1996-03-27 1999-12-28 The Procter & Gamble Co. Conditioning shampoo composition
US6497875B1 (en) 1996-04-26 2002-12-24 Case Western Reserve University Multilayer skin or dermal equivalent having a layer containing mesenchymal stem cells
US5885829A (en) 1996-05-28 1999-03-23 The Regents Of The University Of Michigan Engineering oral tissues
US5811151A (en) 1996-05-31 1998-09-22 Medtronic, Inc. Method of modifying the surface of a medical device
US5836970A (en) 1996-08-02 1998-11-17 The Kendall Company Hemostatic wound dressing
GB2318577B (en) 1996-10-28 2000-02-02 Johnson & Johnson Medical Solvent dried polysaccharide sponges
FR2757874B1 (fr) 1996-12-17 2003-04-25 Biocem Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
US5939039A (en) 1997-01-16 1999-08-17 Orthovita, Inc. Methods for production of calcium phosphate
US5989180A (en) 1997-04-11 1999-11-23 C.R. Bard, Inc. Removable external closure device for managing female urinary incontinence
US6096309A (en) 1997-06-18 2000-08-01 Cohesion Technologies, Inc. Compositions containing thrombin and microfibrillar nanometer collagen, and methods for preparation and use thereof
US5910315A (en) 1997-07-18 1999-06-08 Stevenson; Sharon Allograft tissue material for filling spinal fusion cages or related surgical spaces
US6166184A (en) 1997-08-18 2000-12-26 Medtronic Inc. Process for making a bioprosthetic device
US6095969A (en) 1998-03-03 2000-08-01 Karram; Mickey M. Female incontinence control device actuated by abdominal pressure
GB9804720D0 (en) 1998-03-05 1998-04-29 Unilever Plc Shampoo compositions
US6040493A (en) 1998-04-24 2000-03-21 Replication Medical, Inc. Bioreactor wound dressing
US6432710B1 (en) 1998-05-22 2002-08-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
FR2783429B1 (fr) 1998-09-18 2002-04-12 Imedex Biomateriaux Materiau collagenique bicomposite,son procede d'obtention et ses applications therapeutiques
WO2000045871A1 (en) 1999-02-04 2000-08-10 Sdgi Holdings, Inc. Highly-mineralized osteogenic sponge compositions, and uses thereof
JP4732587B2 (ja) 1999-02-04 2011-07-27 ウォーソー・オーソペディック・インコーポレーテッド 骨形成ペースト組成物およびその用途
US6436101B1 (en) 1999-10-13 2002-08-20 James S. Hamada Rasp for use in spine surgery
US6448278B2 (en) 1999-12-23 2002-09-10 Pfizer Inc. Procollagen C-proteinase inhibitors
ES2304343T3 (es) 2000-03-03 2008-10-16 Syntacoll Ag Agente para el tratamiento de las heridas.
US6630153B2 (en) 2001-02-23 2003-10-07 Smith & Nephew, Inc. Manufacture of bone graft substitutes
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
AT412445B (de) 2000-06-20 2005-03-25 Biering Wolfgang Flüssiges collagen-hämostatikum
AU9109201A (en) 2000-09-18 2002-03-26 Organogenesis Inc Methods for treating a patient using a bioengineered flat sheet graft prostheses
DE10053870A1 (de) 2000-10-31 2002-05-08 Burchardt Elmar Reinhold Procollagen (III)-Propeptide und verwandte Substanzen zur Behandlung von fibrotischen Erkrankungen
US20020082697A1 (en) 2000-12-22 2002-06-27 Damien Christopher J. Implantable osteogenic material
US7041868B2 (en) 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Bioabsorbable wound dressing
US7371403B2 (en) 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
ATE543509T1 (de) 2001-08-13 2012-02-15 Univ Florida Material und verfahren zur förderung der reparatur von nervengewebe
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US7641958B2 (en) 2002-04-25 2010-01-05 Gore Enterprise Holdings, Inc. Membrane for use in sutured or sutureless surgical procedures
US7041309B2 (en) 2002-06-13 2006-05-09 Neuropro Technologies, Inc. Spinal fusion using an HMG-CoA reductase inhibitor
US20040001878A1 (en) 2002-06-26 2004-01-01 Deroyal Industries, Inc. Infused wound care dressings
US20040192658A1 (en) 2002-12-27 2004-09-30 Angiotech International Ag Compositions and methods of using collajolie
GB0309064D0 (en) * 2003-04-22 2003-05-28 Univ Manchester Modified peptides and their uses
GB2408206B (en) * 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
US20060188486A1 (en) 2003-10-14 2006-08-24 Medivas, Llc Wound care polymer compositions and methods for use thereof
DE102004022645A1 (de) 2004-05-07 2005-12-15 Resorba Wundversorgung Gmbh & Co. Kg Bioresorbierbares Material auf Kollagen-Basis
EA012799B1 (ru) * 2004-08-16 2009-12-30 Кварк Фармасьютикалс, Инк. Терапевтические применения ингибиторов rtp801
GB2433029A (en) 2005-12-09 2007-06-13 Ethicon Inc Wound dressings comprising oxidized cellulose and human recombinant collagen
ES2397381T3 (es) 2006-01-12 2013-03-06 Integra Lifesciences Corporation Producto reparador dural y meníngeo suturable que comprende matriz de colágeno
US7939092B2 (en) 2006-02-01 2011-05-10 Warsaw Orthopedic, Inc. Cohesive osteogenic putty and materials therefor
CA2646195C (en) 2006-04-11 2014-07-08 Tyco Healthcare Group Lp Wound dressings with anti-microbial and chelating agents
US7838022B2 (en) 2006-05-01 2010-11-23 Warsaw Orthopedic, Inc Malleable implants containing demineralized bone matrix
ES2565185T3 (es) 2008-04-18 2016-04-01 Collplant Ltd. Métodos de generación y de uso del procolágeno

Also Published As

Publication number Publication date
EP2288376A2 (en) 2011-03-02
US20150328288A1 (en) 2015-11-19
CN102056619A (zh) 2011-05-11
ES2565185T3 (es) 2016-04-01
US20110269667A1 (en) 2011-11-03
WO2009128076A3 (en) 2010-01-28
EP3020410A1 (en) 2016-05-18
CN104491845A (zh) 2015-04-08
US9095569B2 (en) 2015-08-04
CA2721507A1 (en) 2009-10-22
EP2288376B1 (en) 2016-01-13
WO2009128076A2 (en) 2009-10-22
CA2721507C (en) 2017-10-03

Similar Documents

Publication Publication Date Title
PL2288376T3 (pl) Sposoby generowania i wykorzystywania prokolagenu
IL248723A0 (en) Specific antibodies against the bcr complex and methods of using them
EG27167A (en) Microemulsifiers and methods of making and using same
EP2279291A4 (en) COFERONE AND METHOD FOR THE PRODUCTION AND USE THEREOF
HK1172896A1 (zh) 化合物和使用方法
HK1161094A1 (en) Compounds and methods of use
HUE042940T2 (hu) Anti-FXI antitestek és alkalmazási eljárások
EP2373679A4 (en) HEPPIDINE MINI PEPTIDES AND METHODS OF USE
EP2309860A4 (en) MONOCYCLIC CYANOENONES AND METHODS OF USE
HK1147254A1 (en) 5-anilinoimidazopyridines and methods of use 5-
HK1149933A1 (en) Diazacarbazoles and methods of use
EP2126087A4 (en) METHODS FOR PRODUCING PHARMACOTHEQUES, AND USES THEREOF
GB0809278D0 (en) Scooter and method of use thereof
ZA201009224B (en) Il-1a abs and methods of use
EP2255263A4 (en) REACHEMINER WITH TWO REFERENCE CLOCKS AND ITS ACTUATION METHOD
EP2519920A4 (en) METHOD AND DEVICES FOR MODELING USER INTERESTS
IL211623A0 (en) Anti-notch2 antibodies and methods of use
IL209548A0 (en) Diazacarbazoles and methods of use
IL206125A0 (en) Azaindolizines and methods of use
IL226244A (en) Methods for the synthesis of amine thiazolopyridine-2-ylaoxy-phenyl and thiazolopyrazine-2-ylaoxy-phenyl
EP2346521A4 (en) PEPTIDES AND METHODS OF USE
EP2250189A4 (en) GYLCOPEPTIDES AND METHOD FOR THEIR PREPARATION AND USE
EP2300306A4 (en) BICYCLE SOUND GENERATOR AND METHOD OF USE THEREOF
ZA201007681B (en) Cd4-related polypeptides and methods of use
IL208780A0 (en) Methods of generating and using procollagen